Why More Microamps Don't Mean Better Results in EMS
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Share
Walk through the marketing claims of any consumer EMS or microcurrent facial device and you will see microamperage front and center. "335 µA." "500 µA." "680 µA." "Up to 1,000 µA." The implicit logic is that a bigger number means a better device — that microamperage is the metric by which devices should be ranked. The implicit logic is wrong.
Microamperage by itself is one of the least informative numbers on an EMS or microcurrent device's spec sheet. A device with higher peak microamps can produce worse results than a device with lower peak microamps. Understanding why requires looking past the headline number to what microamperage actually measures — and what it doesn't.
What microamps actually measure
A microampere (µA) is one millionth of an ampere — a unit of electrical current. Listed on a device spec sheet, microamperage typically refers to the peak amplitude the circuit can deliver under ideal conditions: the largest pulse, momentarily, into a resistance test load.
That number is real. It is also stripped of context. Microamperage on its own does not tell you:
- What frequency the current is being delivered at
- Whether the waveform is fixed or modulated
- How long each pulse lasts and how often it repeats
- What happens to that current after it passes through skin and tissue
- Whether the device sustains its peak across a full session, or only spikes briefly
Without those variables, the number on its own predicts nothing about real results.
Why frequency matters more than amperage
The most important variable that microamperage doesn't capture is frequency. Electricity at 5 Hz behaves completely differently from electricity at 1,500 Hz, even at identical amperage. The two currents reach different layers of tissue and produce different physiological effects.
Low-frequency current (under 10 Hz) works at the skin's surface — stimulating cellular activity, ATP production, circulation. This is microcurrent territory. It produces brighter, healthier-looking skin, but it does not engage the underlying muscle.
High-frequency current (1–2 kHz) penetrates past the surface and engages the motor neurons that command facial muscles. This is EMS territory. It produces actual contraction, which is what drives structural change.
A 680 µA device operating at low frequency is doing different work than a 500 µA device operating at high frequency. Both numbers may be peak microamps, but they are reporting on completely different categories of treatment. Comparing them directly is a category error. For a deeper read, see Microcurrent Intensity Explained.
The threshold problem
EMS is a threshold technology. Below the motor-contraction threshold (the amplitude at which the muscle begins to involuntarily contract), increasing the microamperage just produces stronger sensation, not more muscle work. Past the threshold, increasing further produces more discomfort, not more contraction.
The relationship is not linear. Doubling the microamperage does not double the muscle response. Once the device crosses the threshold required to recruit the target muscle fibers, adding more current just adds to the user's sensory experience — and to the discomfort that erodes daily compliance.
This is why two devices with very different peak microamps can produce comparable contractions if both cross the threshold, and why a device with an enormous peak microamp number can produce a worse session experience than a more measured one.
Why peak ≠ sustained
"Peak" microamperage is a momentary value. What actually engages your muscle across a 10-minute session is the sustained current — the average across the duration of the treatment.
A device with a high peak that drops sharply between pulses delivers less total current than a lower-peak device sustaining its output evenly. Spec sheets rarely report this distinction. They report the highest single number the circuit can produce, because that is the most marketable figure. Sustained delivery is what does the work.
Triple-Wave is about modulation, not amperage
PureLift's competitive advantage is not that it produces a particularly large peak microamperage. It is that the waveform is engineered for the muscle layer at high frequency (1.37–1.73 kHz), modulated continuously across that range to prevent neuromuscular accommodation, and sustained across the full session.
Triple-Wave Randomized Frequency Modulation is an engineering choice that operates at a different level of the device than peak amperage. It varies frequency, pulse duration, and pulse pattern in real time, which keeps the muscle responding session after session — where fixed-frequency devices show measurable decline (Downey et al., 2011).
The PureLift line is FDA cleared 510(k), designed in Japan to ISO-certified manufacturing standards, with diamond-shaped medical-grade stainless-steel probes. None of those qualities show up as a single number on a competitor's spec sheet. All of them determine real results more reliably than peak microamperage does.
What to look at instead
If microamperage alone shouldn't drive your buying decision, here's what should:
- Frequency range. Low Hz = skin work. kHz = muscle work. Decide which one you want.
- Waveform engineering. Modulated holds effectiveness over time. Fixed frequency plateaus.
- Probe design. Diamond-shaped distributes current evenly. Round bulbs concentrate it.
- Manufacturing precision. Made in Japan / ISO-certified means each unit performs within spec.
- Regulatory status. FDA cleared 510(k) confirms safety review.
For the broader spec-interpretation framework, see Raw Power vs. Usable Power. For the clinical-research case for modulation, see Modulated vs. Fixed Frequency EMS. For the consumer-facing version of the same idea, see Why Stronger-Feeling EMS Devices Aren't Always Better.
The PureLift line
- PureLift Face — entry-level EMS at $499; compact diamond-shaped probe.
- PureLift Pro — standard EMS workhorse at $699.
- PureLift Pro Edition — $799 with LED indicators.
- PureLift Pro Plus — premium tier at $899 with red oval display.
- PureLift Glow — top-tier EMS + LED PDM++ dual therapy at $999.
For optimal EMS conductivity, pair any device with the PureLift Activator Serum.
Further reading: peer-reviewed sources
Behringer M, Grützner S, Montag J, McCourt M, Ring M, Mester J. (2016). Effects of stimulation frequency, amplitude, and impulse width on muscle fatigue. Muscle & Nerve 53(4):608–616 — randomized crossover trial in 13 athletic men: stimulation frequency significantly affected fatigue kinetics; intensity and impulse width did not. The published evidence behind why peak amperage on a spec sheet is not the active variable.
Maffiuletti NA et al. (2018). Clinical Use of Neuromuscular Electrical Stimulation for Neuromuscular Rehabilitation. Archives of Physical Medicine & Rehabilitation 99(4):806–812 — establishes that evoked muscle force is the major determinant of NMES effectiveness, not externally controllable parameters.
For our complete evidence base, see The Research Behind PureLift LAB: 17 Peer-Reviewed Studies on Modulated EMS.